HANK & LIN'S GROUP
The past is prologue and the future is scintillating
2014
1. Graham, Thomas JA, R. Frederick Lambert, Karl Ploessl, Hank F. Kung, and Abigail G. Doyle. "Enantioselective radiosynthesis of positron emission tomography (PET) tracers containing [18F] fluorohydrins." Journal of the American Chemical Society 136, no. 14 (2014): 5291-5294.
2. Liu, Yajing, Feng Yue, Rongping Tang, Guoxian Tao, Xiaomei Pan, Lin Zhu, Hank F. Kung, and Piu Chan. "Progressive loss of striatal dopamine terminals in MPTP-induced acute parkinsonism in cynomolgus monkeys using vesicular monoamine transporter type 2 PET imaging ([18F] AV-133)." Neuroscience Bulletin 30, no. 3 (2014): 409-416.
3. Wang, Limin, Brian P. Lieberman, Karl Ploessl, and Hank F. Kung. "Synthesis and evaluation of 18F labeled FET prodrugs for tumor imaging." Nuclear medicine and biology 41, no. 1 (2014): 58-67.
4. Wu, Zehui, Zhihao Zha, Genxun Li, Brian P. Lieberman, Seok Rye Choi, Karl Ploessl, and Hank F. Kung. "[18F](2 S, 4 S)-4-(3-Fluoropropyl) glutamine as a tumor imaging agent." Molecular pharmaceutics 11, no. 11 (2014): 3852-3866.
5. Zhu, Lin, Karl Ploessl, and Hank F. Kung. "PET/SPECT imaging agents for neurodegenerative diseases." Chemical Society Reviews 43, no. 19 (2014): 6683-6691. DOI: 10.1039/c3cs60430f
6. Graham, Thomas, R. Frederick Lambert, Karl Ploessl, Hank Kung, and Abigail Doyle. "Direct enantioselective radiosynthesis of PET tracers bearing [18F] fluorohydrins utilizing chiral cobalt reagents." Journal of Nuclear Medicine May 2014, 55 (supplement 1)2.
7. Ploessl, Karl, Zhihao Zha, Seok Rye Choi, Lin Zhu, and Hank Kung. "Structural investigation of nat/67/68Ga HBED-CC complexes." Nuclear Medicine and Biology 7, no. 41 (2014): 635.
8. Ploessl, Karl, Brian Lieberman, Zhihao Zha, Genxun Li, and Hank Kung. "Evaluation of (2S, 4S) 4-(3-[18F] F-propyl)-glutamine as a tumor metabolic imaging agent." Journal of Nuclear Medicine May 2014, 55 (supplement 1) 498
9. Rowe, Christopher, Svetlana Pejoska, Yenni Lie, Robyn Veljanovski, Gareth Jones, Hank Kung, Michael Pontecorvo, Mark Mintun, Daniel Skovronsky, and Victor Villemagne. "The management impact of [18F] AV-133 VMAT2 PET in atypical Parkinson’s disease." Journal of Nuclear Medicine May 2014, 55 (supplement 1)1847.
10. Venneti, Sriram, Mark Dunphy, Hanwen Zhang, Kenneth Pitter, Carl Campos, Sean Carlin, Serge Lyashchenko et al. "TM-15GLUTAMINE BASED PET IMAGING FACILITATES ENHANCED METABOLIC DETECTION OF GLIOMAS IN VIVO." Neuro-Oncology 16, no. Suppl 5 (2014): v216.
2013
1. Lemoine, Laetitia, Brian P. Lieberman, Karl Ploessl, Pinguan Zheng, and Hank F. Kung. "Characterization of FlipIDAM as a SERT-selective SPECT imaging agent." Nuclear Medicine and Biology 40, no. 7 (2013): 879-886.
2. Multani, Pushpinder K., Rachel Hodge, Marcel A. Estévez, Ted Abel, Hank Kung, Mark Alter, Bethany Brookshire et al. "VMAT1 deletion causes neuronal loss in the hippocampus and neurocognitive deficits in spatial discrimination." Neuroscience 232 (2013): 32-44.
3. Zheng, Pinguan, Brian P. Lieberman, Karl Ploessl, Laetitia Lemoine, Sara Miller, and Hank F. Kung. "A new single-photon emission computed tomography (SPECT) imaging agent for serotonin transporters:[125I] Flip-IDAM,(2-((2-((dimethylamino) methyl)-4-iodophenyl) thio) phenyl) methanol." Bioorganic & medicinal chemistry letters 23, no. 3 (2013): 869-872.
4. Zhu, Lin, Genxun Li, Seok Rye Choi, Karl Plössl, Piu Chan, Hongwen Qiao, Zhihao Zha, and Hank F. Kung. "An improved preparation of [18F] FPBM: a potential serotonin transporter (SERT) imaging agent." Nuclear Medicine and Biology 40, no. 8 (2013): 974-979.
5. Zhu, Lin, Karl Ploessl, and Hank F. Kung. "Expanding the scope of fluorine tags for PET imaging." Science 342, no. 6157 (2013): 429-430. DOI: 10.1126/science.1245011
6. Graham, Thomas JA, Karl Ploessl, Hank F. Kung, and Abigail G. Doyle. "Enantioselective ring opening of epoxides with [F-18] fluoride." In JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, vol. 56, pp. S74-S74. 111 RIVER ST, HOBOKEN 07030-5774, NJ USA: WILEY-BLACKWELL, 2013.
7. Kung, H. F., et al. "Imaging glutaminolysis in cancer." JOURNAL OF NUCLEAR MEDICINE. Vol. 54. 1850 SAMUEL MORSE DR, RESTON, VA 20190-5316 USA: SOC NUCLEAR MEDICINE INC, 2013.
8. Pejoska, Svetlana, Victor Villemagne, Rachel Mulligan, Gareth Jones, Hank Kung, Michael Pontecorvo, Colin Masters, Mark Mintun, Daniel Skovronsky, and Christopher Rowe. "A management impact study of VMAT2 PET with [18F] AV-133 in patients with uncertain parkinsonian features: Preliminary findings." Journal of Nuclear Medicine May 2013, 54 (supplement 2)1780.
9. Ploessl, Karl, Brian Lieberman, Limin Wang, Seok Rye Choi, and Hank Kung. "Evaluation of (2S, 5R)-and (2S, 5S)-5-[18F] fluoro-6-oxo-lysine as tumor metabolic imaging agents." Journal of Nuclear Medicine May 2013, 54 (supplement 2) 216.
10. Vijayendran, Krishna, Brian Lieberman, Karl Ploessl, and Hank Kung. "Imaging c-MYC driven cancer metabolism with 18F-(2S, 4R) 4-fluoroglutamine." Journal of Nuclear Medicine May 2013, 54 (supplement 2)394.
11. Xue, Zhou, Deng Ai-Fang, Qiao Jin-ping, Yin Wei, Zhu Lin, and Hank F. Kung. "Study the brain uptake of a pseudo-carrier for [F-18]-AV-133 by ultra-performance liquid chromatography tandem mass spectrometry." In JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, vol. 56, pp. S287-S287. 111 RIVER ST, HOBOKEN 07030-5774, NJ USA: WILEY-BLACKWELL, 2013.
12. Lin, Zhu, Li Genxun, Seok Rye Choi, Brian P. Lieberman, Karl Ploessl, Yin Wei, Qiao Jinping, and Hank F. Kung. "An improved preparation of [F-18]-FPBM, a potent serotonin transporter (SERT) imaging agent." In JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, vol. 56, pp. S288-S288. 111 RIVER ST, HOBOKEN 07030-5774, NJ USA: WILEY-BLACKWELL, 2013.
2012
1. Choi, Seok Rye, Julie A. Schneider, David A. Bennett, Thomas G. Beach, Barry J. Bedell, Simone P. Zehntner, Michael J. Krautkramer et al. "Correlation of amyloid PET ligand florbetapir F 18 binding with Aβ aggregation and neuritic plaque deposition in postmortem brain tissue." Alzheimer Disease & Associated Disorders 26, no. 1 (2012): 8-16.
2. Cooper, Arthur JL, Boris F. Krasnikov, John T. Pinto, Hank F. Kung, Jianyong Li, and Karl Ploessl. "Comparative enzymology of (2S, 4R) 4-fluoroglutamine and (2S, 4R) 4-fluoroglutamate." Comparative Biochemistry and Physiology Part B: Biochemistry and Molecular Biology 163, no. 1 (2012): 108-120.
3. Kung, Hank F. "The β-amyloid hypothesis in Alzheimer's disease: seeing is believing." ACS medicinal chemistry letters 3, no. 4 (2012): 265-267.
4. Kung, Hank F., and Karl Ploessl. "[99mTc] TRODAT: dopamine transporter imaging agent for SPECT." In Targeted Molecular Imaging, pp. 271-280. CRC Press, 2012.
5. Kung, Hank F., and Karl Ploessl. "14.[99mTc] TRODAT." Targeted Molecular Imaging (2012): 253.
6. Ploessl, Karl, Limin Wang, Brian P. Lieberman, Wenchao Qu, and Hank F. Kung. "Comparative evaluation of 18F-labeled glutamic acid and glutamine as tumor metabolic imaging agents." Journal of nuclear medicine 53, no. 10 (2012): 1616-1624.
7. Qiao, Hongwen, Lin Zhu, Brian P. Lieberman, Zhihao Zha, Karl Plössl, and Hank F. Kung. "Synthesis and evaluation of novel tropane derivatives as potential PET imaging agents for the dopamine transporter." Bioorganic & medicinal chemistry letters 22, no. 13 (2012): 4303-4306.
8. Qu, Wenchao, Shunichi Oya, Brian P. Lieberman, Karl Ploessl, Limin Wang, David R. Wise, Chaitanya R. Divgi, Lewis P. Chodosh, Craig B. Thompson, and Hank F. Kung. "Preparation and characterization of L-[5-11C]-glutamine for metabolic imaging of tumors." Journal of Nuclear Medicine 53, no. 1 (2012): 98-105.
9. Villemagne, V.L., Okamura, N., Pejoska, S., Drago, J., Mulligan, R.S., Chételat, G., O’Keefe, G., Jones, G., Kung, H.F., Pontecorvo, M. and Masters, C.L. "Differential diagnosis in Alzheimer’s disease and dementia with Lewy bodies via VMAT2 and amyloid imaging." Neurodegenerative Diseases 10, no. 1-4 (2012): 161-165.
10. Wang, Limin, Zhihao Zha, Wenchao Qu, Hongwen Qiao, Brian P. Lieberman, Karl Plössl, and Hank F. Kung. "Synthesis and evaluation of 18F labeled alanine derivatives as potential tumor imaging agents." Nuclear medicine and biology 39, no. 7 (2012): 933-943.
11. Zhu, Lin, Hongwen Qiao, Brian P. Lieberman, Jingxiao Wu, Yajing Liu, Zhongyun Pan, Karl Ploessl, Seok Rye Choi, Piu Chan, and Hank F. Kung. "Imaging of VMAT2 binding sites in the brain by 18F-AV-133: The effect of a pseudo-carrier." Nuclear medicine and biology 39, no. 7 (2012): 897-904.
12. Haase, Danniebelle N., Xuanwen Li, Ashmita Saigal, Karl Ploeessl, Tilo Grosser, Garret A. FitzGerald, and Hank F. Kung. "Preparation and evaluation of new 1, 5-diarylpyrazoles as potential probes for imaging cyclooxygenase-2 (COX-2) expression in the brain." In ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, vol. 244. 1155 16TH ST, NW, WASHINGTON, DC 20036 USA: AMER CHEMICAL SOC, 2012.
2011
1. Carberry, Patrick, Alan P. Carpenter, and Hank F. Kung. "Fluoride-18 radiolabeling of peptides bearing an aminooxy functional group to a prosthetic ligand via an oxime bond." Bioorganic & medicinal chemistry letters 21, no. 23 (2011): 6992-6995.
2. Carberry, Patrick, Brian P. Lieberman, Karl Ploessl, Seok R. Choi, Danniebelle N. Haase, and Hank F. Kung. "New F-18 prosthetic group via oxime coupling." Bioconjugate chemistry 22, no. 4 (2011): 642-653.
3. Clark, Christopher M., Julie A. Schneider, Barry J. Bedell, Thomas G. Beach, Warren B. Bilker, Mark A. Mintun, Michael J. Pontecorvo et al. "Use of florbetapir-PET for imaging β-amyloid pathology." Jama 305, no. 3 (2011): 275-283.
4. Lieberman, Brian P., Karl Ploessl, Limin Wang, Wenchao Qu, Zhihao Zha, David R. Wise, Lewis A. Chodosh, George Belka, Craig B. Thompson, and Hank F. Kung. "PET imaging of glutaminolysis in tumors by 18F-(2S, 4R) 4-fluoroglutamine." Journal of nuclear medicine 52, no. 12 (2011): 1947-1955.
5. Lister-James, John, et al. "Florbetapir f-18: a histopathologically validated Beta-amyloid positron emission tomography imaging agent." Seminars in nuclear medicine. Vol. 41. No. 4. WB Saunders, 2011.
6. Liu, Jingying, Lin Zhu, Karl Plössl, Brian P. Lieberman, and Hank F. Kung. "Synthesis and evaluation of novel N-fluoropyridyl derivatives of tropane as potential PET imaging agents for the dopamine transporter." Bioorganic & medicinal chemistry letters 21, no. 10 (2011): 2962-2965.
7. Qu, Wenchao, Zhihao Zha, Karl Ploessl, Brian P. Lieberman, Lin Zhu, David R. Wise, Craig B. Thompson, and Hank F. Kung. "Synthesis of optically pure 4-fluoro-glutamines as potential metabolic imaging agents for tumors." Journal of the American Chemical Society 133, no. 4 (2011): 1122-1133.
8. Qu, Wenchao, Zhihao Zha, Brian P. Lieberman, Anthony Mancuso, Mathew Stetz, Rahim Rizzi, Karl Ploessl, David Wise, Craig Thompson, and Hank F. Kung. "Facile synthesis [5-13C-4-2H2]-L-glutamine for hyperpolarized MRS imaging of cancer cell metabolism." Academic radiology 18, no. 8 (2011): 932-939.
9. Richardson-Jones JW, Craige CP, Nguyen TH, Kung HF, Gardier AM, Dranovsky A, David DJ, Guiard BP, Beck SG, Hen R, Leonardo ED. Serotonin-1A autoreceptors are necessary and sufficient for the normal formation of circuits underlying innate anxiety. Journal of Neuroscience. 2011 Apr 20;31(16):6008-18.
10. Villemagne, Victor L., Nobuyuki Okamura, Svetlana Pejoska, John Drago, Rachel S. Mulligan, Gaël Chételat, Uwe Ackermann et al. "In vivo assessment of vesicular monoamine transporter type 2 in dementia with lewy bodies and Alzheimer disease." Archives of neurology 68, no. 7 (2011): 905-912.
11. Virostko J, Henske J, Vinet L, Lamprianou S, Dai C, Radhika A, Baldwin RM, Ansari MS, Hefti F, Skovronsky D, Kung HF. Multimodal image coregistration and inducible selective cell ablation to evaluate imaging ligands. Proceedings of the National Academy of Sciences. 2011 Dec 20;108(51):20719-24.
12. Wang, Limin, Brian P. Lieberman, Karl Plössl, Wenchao Qu, and Hank F. Kung. "Synthesis and comparative biological evaluation of L-and D-isomers of 18F-labeled fluoroalkyl phenylalanine derivatives as tumor imaging agents." Nuclear medicine and biology 38, no. 3 (2011): 301-312.
13. Wang, Limin, Wenchao Qu, Brian P. Lieberman, Karl Plössl, and Hank F. Kung. "Synthesis, uptake mechanism characterization and biological evaluation of 18F labeled fluoroalkyl phenylalanine analogs as potential PET imaging agents." Nuclear medicine and biology 38, no. 1 (2011): 53-62
14. Zha, Zhihao, Seok Rye Choi, Karl Ploessl, Brian P. Lieberman, Wenchao Qu, Franz Hefti, Mark Mintun, Daniel Skovronsky, and Hank F. Kung. "Multidentate 18F-polypegylated styrylpyridines as imaging agents for Aβ plaques in cerebral amyloid angiopathy (CAA)." Journal of medicinal chemistry 54, no. 23 (2011): 8085-8098.
15. Zha, Zhihao, Lin Zhu, Yajing Liu, Fenghua Du, Hongmei Gan, Jinping Qiao, and Hank F. Kung. "Synthesis and evaluation of two novel 2-nitroimidazole derivatives as potential PET radioligands for tumor imaging." Nuclear medicine and biology 38, no. 4 (2011): 501-508.
16. Zheng, Pinguan, Brian P. Lieberman, Seok Rye Choi, Karl Plöessl, and Hank F. Kung. "Synthesis and biological evaluation of 3-alkyl-dihydrotetrabenazine derivatives as vesicular monoamine transporter-2 (VMAT2) ligands." Bioorganic & medicinal chemistry letters 21, no. 11 (2011): 3435-3438.
17. Zhou, Xue, Jinping Qiao, Wei Yin, Lin Zhu, and Hank F. Kung. "Determination of the penetration of 9-fluoropropyl-(+)-dihydrotetrabenazine across the blood–brain barrier in rats by microdialysis combined with liquid chromatography–tandem mass spectrometry." Journal of Chromatography B 879, no. 28 (2011): 3041-3046.
18. Zhou, Xue, Jinping Qiao, Wei Yin, Lin Zhu, and Hank F. Kung. "Study the effect of a pseudo-carrier on pharmacokinetics of 9-fluoropropyl-(+)-dihydrotetrabenazine in rat plasma by ultra-performance liquid chromatography–tandem mass spectrometry." Journal of Chromatography B 879, no. 7-8 (2011): 505-510.
19. Carberry, Patrick, Brian P. Lieberman, Karl Ploessl, Seok R. Choi, Alan P. Carpenter, and Hank F. Kung. "The development and application of a novel F-18 prosthetic ligand fluoro-PEG-benzaldehyde (FPBA)." Journal of Labelled Compounds and Radiopharmaceuticals 54 (2011): S468-S468.
20. Haase, Danniebelle N., Brian P. Lieberman, Karl Ploeessl, and Hank F. Kung. "Preparation of potential serotonin transporter (SERT) inhibitors for diagnosing depression." In ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, vol. 242. 1155 16TH ST, NW, WASHINGTON, DC 20036 USA: AMER CHEMICAL SOC, 2011.
21. Oya, Shunichi, Wang Limin, Qu Wenchao, Brian P. Lieberman, Karl Ploessl, Boby Mathew, Rajesh M. Kamble, Chaitanya Divgi, Craig B. Thompson, and Hank F. Kung. "Stereo-selective synthesis of C-11 labeled L-glutamine for imaging glutaminolysis in tumor cells." In JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, vol. 54, pp. S105-S105. COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA: WILEY-BLACKWELL, 2011.
22. Ploessl, Karl, Limin Wang, Brian Lieberman, Wenchao Qu, and Hank Kung. "Evaluation of (2S, 4R)-and (2S, 4S)-4 [18F] Fluoro-L-glutamine as tumor metabolic imaging agents." Journal of Nuclear Medicine May 2011, 52 (supplement 1) 1495;
23. Ploessl, Karl, Wenchao Qu, Brian Lieberman, Limin Wang, and Hank Kung. "Radiosynthesis of optically pure 4-[18F] fluoro-L-glutamate: Metabolic imaging agents for tumors." Journal of Nuclear Medicine May 2011, 52 (supplement 1) 1497.
24. Ploessl, Karl, Limin Wang, Brian Lieberman, Wenchao Qu, and Hank Kung. "Comparison of cell uptake of fluorine-18 labeled (2S, 4R)-4-fluoro-glutamine (FGln) and (2S, 4R)-4-fluoro-glutamic acid (FGlu)." Journal of Nuclear Medicine May 2011, 52 (supplement 1) 1569.
25. Qiao, Hongwen, Pinguan Zheng, Karl Ploessl, Lin Zhu, and Hank Kung. "Rapid and efficient labeling of 18F-FPBM: A PET agent for mapping serotonin transporters in the brain." Journal of Nuclear Medicine May 2011, 52 (supplement 1) 1435;
26. Qiao, Jinping, Xue Zhou, Lin Zhu, Hank Kung, and Wei Yin. "Simultaneous determination of AV-133 in rat brain and blood by microdialysis combined with LC-MS/MS." Journal of Nuclear Medicine May 2011, 52 (supplement 1) 226.
27. Hongwen, Qiao, Zhi Zhihao, Brian P. Lieberman, Wang Limin, Karl Ploessl, Zhu Lin, and Hank F. Kung. "Syntheses and optimization of radiolabeling conditions for [F-18] Acetyloxy AV-45: a novel A beta plaques imaging agent." In JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, vol. 54, pp. S522-S522. COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA: WILEY-BLACKWELL, 2011.
28. Limin, Wang, Zha Zhihao, Qu Wenchao, Qiao Hongwen, Brian Lieberman, Karl Ploessl, and Hank Kung. "Synthesis and evaluation of F-18 labeled fluoroalanine derivatives as potential tumor imaging agents." In JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, vol. 54, pp. S7-S7. COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA: WILEY-BLACKWELL, 2011.
29. Zha, Zhihao, Seok Rye Choi, Brian Lieberman, Karl Ploessl, Wenchao Qu, Daniel Skovronsky, Franz Hefti, and Hank Kung. "18F-AV45 dimer: A PET agent for mapping Aβ deposits for cerebral angiopathy." Journal of Nuclear Medicine May 2011, 52 (supplement 1) 27.
30. Pinguan, Zheng, Qiao Hongwen, Brian P. Lieberman, Karl Ploessl, Lin Zhu, and Hank F. Kung. "Improved synthesis and radiolabeling of [F-18] FPBM: a new serotonin transporter imaging agent." In JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, vol. 54, pp. S523-S523. COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA: WILEY-BLACKWELL, 2011.
31. Zhou, Xue, Jin-ping Qiao, Wei Yin, Lin Zhu, and Hank F. Kung. "LC-MS/MS determination of AV-133 in microdialysis samples from rat brain and plasma." In JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, vol. 54, pp. S271-S271. COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA: WILEY-BLACKWELL, 2011.
2010
1. Hefti, Franz F., Hank F. Kung, Michael R. Kilbourn, Alan P. Carpenter, Christopher M. Clark, and Daniel M. Skovronsky. "18F-AV-133: a selective VMAT2-binding radiopharmaceutical for PET imaging of dopaminergic neurons." PET clinics 5, no. 1 (2010): 75-82.
2. Kung, Hank F., Seok Rye Choi, Wenchao Qu, Wei Zhang, and Daniel Skovronsky. "18F stilbenes and styrylpyridines for PET imaging of Aβ plaques in Alzheimer’s disease: a miniperspective." Journal of medicinal chemistry 53, no. 3 (2010): 933-941.
3. Kung, HANK F. "Radiochemistry of SPECT: Examples of 99mTc and 111In Complexes." Molecular Imaging: Principles and Practice (2010): 327.
4. Liu, Yajing, Lin Zhu, Karl Plössl, Seok Rye Choi, Hongwen Qiao, Xiaotao Sun, Song Li, Zhihao Zha, and Hank F. Kung. "Optimization of automated radiosynthesis of [18F] AV-45: a new PET imaging agent for Alzheimer's disease." Nuclear medicine and biology 37, no. 8 (2010): 917-925.
5. Okamura, Nobuyuki, Victor L. Villemagne, John Drago, Svetlana Pejoska, Rajinder K. Dhamija, Rachel S. Mulligan, Julia R. Ellis et al. "In vivo measurement of vesicular monoamine transporter type 2 density in Parkinson disease with 18F-AV-133." Journal of Nuclear Medicine 51, no. 2 (2010): 223-228.
6. Pejoska, Svetlana, Christopher C. Rowe, John Drago, Nobuyuki Okamura, Rachel Mulligan, Hank F. Kung, Michael Pontecorvo, Colin L. Masters, Daniel Skovronsky, and Victor L. Villemagne. "IC‐P‐018: 18F‐AV‐133 VMAT2 imaging in the differential diagnosis of dementia with Lewy Bodies from Alzheimer's disease." Alzheimer's & Dementia 6 (2010): S12-S12.
7. Richardson-Jones, Jesse W., Caryne P. Craige, Bruno P. Guiard, Alisson Stephen, Kayla L. Metzger, Hank F. Kung, Alain M. Gardier et al. "5-HT1A autoreceptor levels determine vulnerability to stress and response to antidepressants." Neuron 65, no. 1 (2010): 40-52.
8. Song PJ, Barc C, Arlicot N, Guilloteau D, Bernard S, Sarradin P, Chalon S, Garreau L, Kung HF, Lantier F, Vergote J. Evaluation of prion deposits and microglial activation in scrapie-infected mice using molecular imaging probes. Molecular imaging and biology. 2010 Dec;12(6):576-82.
9. Tu, Zhude, Jinbin Xu, Lynne A. Jones, Shihong Li, Dexing Zeng, Mei-Ping Kung, Hank F. Kung, and Robert H. Mach. "Radiosynthesis and biological evaluation of a promising σ2-receptor ligand radiolabeled with fluorine-18 or iodine-125 as a PET/SPECT probe for imaging breast cancer." Applied Radiation and Isotopes 68, no. 12 (2010): 2268-2273.
10. Wang, Limin, Wenchao Qu, Brian Lieberman, Karl Ploessl, and Hank F. Kung. "Synthesis and in vitro evaluation of 18F labeled tyrosine derivatives as potential positron emission tomography (PET) imaging agents." Bioorganic & medicinal chemistry letters 20, no. 12 (2010): 3482-3485.
11. Wang, Julie L., Eric C. Deutsch, Shunichi Oya, and Hank F. Kung. "FlipADAM: a potential new SPECT imaging agent for the serotonin transporter." Nuclear medicine and biology 37, no. 5 (2010): 577-586.
12. Wang, Julie L., Shunichi Oya, Ajit K. Parhi, Brian P. Lieberman, Karl Ploessl, Catherine Hou, and Hank F. Kung. "In vivo studies of the SERT-selective [18 F] FPBM and VMAT2-selective [18 F] AV-133 radiotracers in a rat model of Parkinson's disease☆." Nuclear Medicine and Biology 37 (2010): 479-486.
13. Wong, Dean F., Paul B. Rosenberg, Yun Zhou, Anil Kumar, Vanessa Raymont, Hayden T. Ravert, Robert F. Dannals et al. "In vivo imaging of amyloid deposition in Alzheimer disease using the radioligand 18F-AV-45 (flobetapir F 18)." Journal of nuclear medicine 51, no. 6 (2010): 913-920.
14. Zhu, Lin, Yajing Liu, Karl Plössl, Brian Lieberman, Jingying Liu, and Hank F. Kung. "An improved radiosynthesis of [18F] AV-133: a PET imaging agent for vesicular monoamine transporter 2." Nuclear medicine and biology 37, no. 2 (2010): 133-141.
15. Lieberman, Brian, Wenchao Qu, Karl Ploessl, David Wise, Chaitanya Divgi, Craig Thompson, and Hank Kung. "Uptake of optically pure 18F-4-fluoro-L-glutamines in tumor cells by glutaminolysis." Journal of Nuclear Medicine May 2010, 51 (supplement 2) 249
16. Liu, Jingying, Lin Zhu, Karl Ploessl, Brian Lieberman, and Hank Kung. "Synthesis and evaluation of 2β-(N-halopyridylaminomethyl)-3β-(4-chlorophenyl) tropanes as potential PET ligands for dopamine transporter." Journal of Nuclear Medicine May 2010, 51 (supplement 2) 299.
17. Qu, Wenchao, Zhihao Zha, Karl Ploessl, Brian Lieberman, Lin Zhu, David Wise, Craig Thompson, and Hank Kung. "Synthesis of optically pure 4-fluoro-L-glutamines as potential tumor imaging agents." Journal of Nuclear Medicine May 2010, 51 (supplement 2) 1507.
18. Qu, Wenchao, Zhihao Zha, Anthony Mancuso, Matthew Stetz, Hans Kim, Stephen Pickup, Rahim Rizi, and Hank Kung. "Synthesis of carbon-13 and deuterium labeled L-glutamine as potential tumor detecting agent." Journal of Nuclear Medicine May 2010, 51 (supplement 2) 220.
19. Villemagne, Victor, John Drago, Svetlana Pejoska, Nobuyuki Okamura, Rachel Mulligan, Hank Kung, Michael Pontecorvo, Colin Masters, Daniel Skovronsky, and Christopher Rowe. "Differential diagnosis of dementia with Lewy bodies from Alzheimer’s disease using [18F]-AV-133, a novel PET tracer for VMAT2." Journal of Nuclear Medicine May 2010, 51 (supplement 2) 442
20. Wang, Limin, Wenchao Qu, Brian Lieberman, Karl Ploessl, and Hank Kung. "Synthesis and in vitro evaluation of F-18 labeled fluoroalkyl phenylalanine derivatives as potential PET imaging agents." Journal of Nuclear Medicine May 2010, 51 (supplement 2) 297.
21. Zhu, Lin, Jingxiao Wu, Hongwen Qiao, Xiaotao Sun, Yajing Liu, and Hank Kung. "A comparative dynamic PET imaging of monkey brains between solid phase extraction and HPLC purified 18F AV-133.” Journal of Nuclear Medicine May 2010, 51 (supplement 2) 584.
